{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:27:36Z","timestamp":1787686056478,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"DOI":"10.1007\/s00246-026-04170-x","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:18:44Z","timestamp":1769591924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Evolving Role of Corticosteroids in Kawasaki Disease: Evidence, Mechanisms, and Clinical Implications"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6008-3563","authenticated-orcid":false,"given":"Phuoc Sang","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0400-8773","authenticated-orcid":false,"given":"Hoang Minh Duc","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"4170_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fped.2018.00374","volume":"6","author":"AH Rowley","year":"2018","unstructured":"Rowley AH, Shulman ST (2018) The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr 6:374","journal-title":"Front Pediatr"},{"issue":"1","key":"4170_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","volume":"153","author":"AH Tremoulet","year":"2008","unstructured":"Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E et al (2008) Resistance to intravenous Immunoglobulin in children with Kawasaki disease. J Pediatr 153(1):117\u2013121","journal-title":"J Pediatr"},{"issue":"9826","key":"4170_CR3","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T et al (2012) Efficacy of Immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613\u20131620","journal-title":"Lancet"},{"issue":"5","key":"4170_CR4","first-page":"CD011188","volume":"5","author":"J Green","year":"2022","unstructured":"Green J, Wardle AJ, Tulloh RM (2022) Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 5(5):CD011188","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"4170_CR5","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS et al (2024) Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation 150(23):e481\u2013e500","journal-title":"Circulation"},{"issue":"1","key":"4170_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13063-022-07051-9","volume":"24","author":"D Eleftheriou","year":"2023","unstructured":"Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM et al (2023) Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Trials 24(1):60","journal-title":"Trials"},{"issue":"8","key":"4170_CR7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M et al (2020) JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J 84(8):1348\u20131407","journal-title":"Circ J"},{"key":"4170_CR8","unstructured":"Galeotti C, Bayry J (2016) Predisposing factors, pathogenesis and therapeutic options in Kawasaki disease. Autoimmun Rev, 15 (10)"},{"key":"4170_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813948","author":"HC Kuo","year":"2023","unstructured":"Kuo HC (2023) Diagnosis, progress, and treatment update of Kawasaki disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241813948","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4170_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/archdischild-2014-307397","volume":"100","author":"S Davies","year":"2015","unstructured":"Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ et al (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100(4):366\u2013368","journal-title":"Arch Dis Child"},{"issue":"7","key":"4170_CR11","doi-asserted-by":"publisher","first-page":"ofae352","DOI":"10.1093\/ofid\/ofae352","volume":"11","author":"VM Karandikar","year":"2024","unstructured":"Karandikar VM, Khan H, Kim KA, Kociolek LK, Jhaveri R et al (2024) Coronary artery outcomes in Kawasaki disease by treatment day within 10 days of fever onset. Open Forum Infect Dis 11(7):ofae352","journal-title":"Open Forum Infect Dis"},{"key":"4170_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1415941","volume":"12","author":"XX Yi","year":"2024","unstructured":"Yi XX, Zhang WR, Wang DM, Wang XP, Zhang FX (2024) Research perspective in the clinical management of Kawasaki disease. Front Pediatr 12:1415941","journal-title":"Front Pediatr"},{"issue":"12","key":"4170_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jpids\/piae112","volume":"13","author":"AP Wang","year":"2024","unstructured":"Wang AP, Khan H, Dong S, Kim KA, Jone PN et al (2024) Primary adjunctive corticosteroids in the acute management of High-Risk Kawasaki disease in a North American cohort. J Pediatr Infect Dis Soc 13(12):626\u2013632","journal-title":"J Pediatr Infect Dis Soc"},{"key":"4170_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1149519","volume":"11","author":"Y Pan","year":"2023","unstructured":"Pan Y, Fan Q, Hu L (2023) Treatment of immunoglobulin-resistant kawasaki disease: a Bayesian network meta-analysis of different regimens. Front Pediatr 11:1149519","journal-title":"Front Pediatr"},{"issue":"7","key":"4170_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMoa061235","volume":"356","author":"JW Newburger","year":"2007","unstructured":"Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W et al (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356(7):663\u2013675","journal-title":"N Engl J Med"},{"issue":"12","key":"4170_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2352-4642(18)30293-1","volume":"2","author":"K Miyata","year":"2018","unstructured":"Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T et al (2018) Efficacy and safety of intravenous Immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. Lancet Child Adolesc Health 2(12):855\u2013862","journal-title":"Lancet Child Adolesc Health"},{"key":"4170_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1636339","volume":"13","author":"A Marchesi","year":"2025","unstructured":"Marchesi A, Recupero R, Sardella L, Babini R, Gargiullo L et al (2025) The protective role of steroids on coronary arteries in the acute phase of Kawasaki disease for high risk patients: a retrospective study. Front Pediatr 13:1636339","journal-title":"Front Pediatr"},{"key":"4170_CR18","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T et al (2018) Efficacy of prednisolone plus intravenous immunoglobulin for prevention of coronary artery abnormalities in high-risk Kawasaki disease: post-RAISE registry analysis. Eur J Pediatr 177:1123\u20131131"},{"issue":"1","key":"4170_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","volume":"47","author":"A Marchesi","year":"2021","unstructured":"Marchesi A, Rigante D, Cimaz R, Ravelli A, de Tarissi Jacobis I et al (2021) Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr 47(1):16","journal-title":"Ital J Pediatr"},{"key":"4170_CR20","doi-asserted-by":"crossref","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M et al (2023) JCS\/JSCVS 2023 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J 87:1348\u20131407","DOI":"10.1253\/circj.CJ-19-1094"},{"key":"4170_CR21","volume-title":"Addendum to the guidelines for diagnosis and management of Kawasaki disease: Japanese society for pediatric cardiology & cardiac surgery KD update 2023","author":"JCS Surgery","year":"2023","unstructured":"Surgery JCS, Kawasaki Disease Committee; Japanese Society for Pediatric Cardiology and Cardiac (2023) Addendum to the guidelines for diagnosis and management of Kawasaki disease: Japanese society for pediatric cardiology & cardiac surgery KD update 2023. Japanese Circulation Society, Tokyo"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04170-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04170-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04170-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:18:47Z","timestamp":1769591927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04170-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":21,"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04170-x","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}